Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-101069

ADURO BIOTECH, INC. · ADRO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 18, 2016
Accepted (ET)
Feb 22, 2016 · 5:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 18, 2016X44,215$1.66A19,087,733D
Common StockFeb 18, 2016X241,260$0.0001A19,328,993D
Common StockFeb 18, 2016X150,787$0.0001A19,479,780D
Common StockFeb 18, 2016X60,315$0.0001A19,540,095D
Common StockFeb 18, 2016X33,179$0.01A19,573,274D
Common StockFeb 18, 2016X232,258$0.01A19,805,532D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Common Stock Warrant (right to buy)$1.66Feb 18, 2016X44,215DApr 15, 2011Apr 15, 2016Common Stock44,2150D
Common Stock Warrant (right to buy)$0.0001Feb 18, 2016X241,260DJun 20, 2011Apr 15, 2021Common Stock241,2600D
Common Stock Warrant (right to buy)$0.0001Feb 18, 2016X150,787DOct 31, 2011Apr 15, 2021Common Stock150,7870D
Common Stock Warrant (right to buy)$0.0001Feb 18, 2016X60,315DApr 15, 2011Apr 15, 2021Common Stock60,3150D
Common Stock Warrant (right to buy)$0.01Feb 18, 2016X33,179DDec 31, 2013Dec 31, 2023Common Stock33,1790D
Common Stock Warrant (right to buy)$0.01Feb 18, 2016X232,258DAug 12, 2013Aug 12, 2023Common Stock232,2580D